Healthcare

>

Biotechnology

>

OTC:
HMTXF

Hemostemix Inc

Recent publications about $HMTXF

Hemostemix Announces Financing

Hemostemix Announces Financing Calgary, Alberta–(Newsfile Corp. – May 19, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company“) is pleased to announce

Hemostemix Announces Closing of $2,750,000

Hemostemix Announces Closing of $2,750,000 Calgary, Alberta–(Newsfile Corp. – April 25, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“)

Hemostemix Announces Settlement Agreement

Hemostemix Announces Settlement Agreement Calgary, Alberta–(Newsfile Corp. – March 23, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company“) is pleased

Register by Email

or
Already a member? Sign In